Tandem Diabetes Care traded at $59.78 this Friday July 1st, increasing $0.59 or 0.99 percent since the previous trading session. Looking back, over the last four weeks, Tandem Diabetes Care gained 11.01 percent. Over the last 12 months, its price fell by 39.38 percent. Looking ahead, we forecast Tandem Diabetes Care to be priced at 59.87 by the end of this quarter and at 55.16 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
59.78
Daily Change
0.99%
Yearly
-39.38%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 247.44 -0.07 -0.03% -21.95%
Abbott 108.40 -0.24 -0.22% -8.17%
Align Technology 241.44 4.77 2.02% -61.32%
Accuray 1.91 -0.05 -2.55% -56.69%
AtriCure 40.70 -0.16 -0.39% -49.77%
Natus Medical 32.75 -0.02 -0.06% 23.40%
Baxter International 64.40 0.17 0.26% -21.23%
Becton, Dickinson and Co. 247.98 1.45 0.59% -0.19%
Boston Scientific 37.28 0.01 0.03% -15.12%
Cooper Companies 315.01 1.89 0.60% -22.74%
Cardiovascular Systems 14.51 0.15 1.04% -65.99%
Dexcom 75.99 1.46 1.96% -82.39%
Edwards Lifesciences 95.35 0.26 0.27% -10.55%
Globus Medical 56.23 0.09 0.16% -28.61%
Integra LifeSciences 54.17 0.14 0.26% -22.50%
ICU Medical 165.60 1.21 0.74% -20.33%
Inogen 24.07 -0.11 -0.45% -62.47%
Intuitive Surgical 200.95 0.24 0.12% -78.58%
J&J 177.12 -0.38 -0.21% 4.82%
Eli Lilly 319.25 -4.98 -1.54% 36.45%
Masimo 133.77 3.10 2.37% -46.92%
Medtronic 89.65 -0.10 -0.11% -29.31%
Merit Medical Systems 54.92 0.65 1.20% -14.21%
NuVasive 48.68 -0.48 -0.98% -27.77%
Orthofix International 23.47 -0.07 -0.30% -42.02%
Insulet 222.72 4.78 2.19% -20.84%
Roche Holding 320.40 1.85 0.58% -8.34%
Stryker 198.82 -0.11 -0.06% -25.09%
Teleflex 252.64 6.79 2.76% -38.38%
Tandem Diabetes Care 59.78 0.59 0.99% -39.38%
Zimmer Biomet Holdings Inc 104.95 -0.11 -0.10% -35.82%

Indexes Price Day Year
USND 10981 -47.56 -0.43% -24.99%
US2000 1704 -4.09 -0.24% -26.10%

Tandem Diabetes Care
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. Its Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.